John C. Neal partners with pharmaceutical and biotech clients to develop market access assessments and launch strategies designed to ensure successful commercialization of assets.
He has deep therapeutic experience in multiple sclerosis, immuno oncology, and vaccines, and has a passion for helping clients solve difficult access hurdles for novel, next generation therapeutics and public health initiatives.
Prior to joining Avalere, John held a variety of consulting and biotech industry leadership positions. He has consulted on numerous specialty product launches in therapeutic areas including atopic dermatitis, cardiovascular disease, and orphan indications myasthenia gravis and immune thrombocytopenia. His most recent industry experience was as vice president of Market Access Strategy and Payer Marketing with EMD Serono, where he lead a team that developed the strategy and execution across the portfolio of Part B and Part D products. In addition, he led the market access launch activities for EMD Serono’s oncology and multiple sclerosis products. Prior to EMD, he spent over 13 years with GSK and Novartis in US and global vaccine commercialization.
John Neal hold a BSc in chemistry from the University of Illinois at Champaign/Urbana and an MBA in marketing from Drake University.
Authored Content
For even deeper coverage, download the 2021 Healthcare Industry Outlook document below.